| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
After the honeymoon: Real world experiences with CFTR modulators
|
Dellon, Elisabeth P.
|
|
|
24 |
4 |
p. 637-638
|
artikel
|
| 2 |
Application of the defect distribution index to functional lung MRI of pediatric cystic fibrosis lung disease and controls
|
Kieninger, Elisabeth
|
|
|
24 |
4 |
p. 809-815
|
artikel
|
| 3 |
A standard operating procedure for reducing risk from medications prohibited during clinical trials in cystic fibrosis
|
Le Sayec, M.
|
|
|
24 |
4 |
p. 667-668
|
artikel
|
| 4 |
Bone mineral density in children and adolescents with cystic fibrosis: a longitudinal study
|
Tamer, G
|
|
|
24 |
4 |
p. 749-754
|
artikel
|
| 5 |
Cancer screening & beyond: The increasing need for primary care in cystic fibrosis
|
Whelan, Karina Z.
|
|
|
24 |
4 |
p. 639-641
|
artikel
|
| 6 |
Cannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis
|
West, Natalie E.
|
|
|
24 |
4 |
p. 691-697
|
artikel
|
| 7 |
Cardiovascular function in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A cross-sectional, observational, single-centre study
|
Clayton, Lauren J
|
|
|
24 |
4 |
p. 801-808
|
artikel
|
| 8 |
CF airway epithelia display exaggerated host defense responses and prolonged cilia loss during RSV infection
|
Bartlett, Jennifer A.
|
|
|
24 |
4 |
p. 759-768
|
artikel
|
| 9 |
CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis
|
Dumortier, Claire
|
|
|
24 |
4 |
p. 741-748
|
artikel
|
| 10 |
Contents
|
|
|
|
24 |
4 |
p. i-iii
|
artikel
|
| 11 |
CyFidb: A Molecular Atlas for Cystic Fibrosis
|
Pereira, Catarina
|
|
|
24 |
4 |
p. 769-777
|
artikel
|
| 12 |
Cystic Fibrosis-related neurodegenerative disease associated with tauopathy and cognitive decline in aged CF mice
|
Patton-Parfyonov, Danica F.
|
|
|
24 |
4 |
p. 778-786
|
artikel
|
| 13 |
Fecal microbiota changes in people with cystic fibrosis after 6 months of elexacaftor/tezacaftor/ivacaftor: Findings from the promise study
|
Duong, Jennifer T
|
|
|
24 |
4 |
p. 792-800
|
artikel
|
| 14 |
Hemoglobin A1c in youth and adults with cystic fibrosis related diabetes decreases after elexacaftor-tezacaftor-ivacaftor
|
Wood, Colleen
|
|
|
24 |
4 |
p. 755-758
|
artikel
|
| 15 |
Impact of CFTR modulator therapy on basic life needs and financial concerns in people with cystic fibrosis: Data from the Well-ME survey
|
Boas, Heather
|
|
|
24 |
4 |
p. 660-666
|
artikel
|
| 16 |
Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
|
Caley, L.R.
|
|
|
24 |
4 |
p. 787-791
|
artikel
|
| 17 |
LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis
|
Vega-Hernandez, Gabriela
|
|
|
24 |
4 |
p. 716-723
|
artikel
|
| 18 |
Long-term outcomes in people with CF lacking FEV1 response to elexacaftor/tezacaftor/ivacaftor therapy
|
Hadhud, Mohamad
|
|
|
24 |
4 |
p. 710-715
|
artikel
|
| 19 |
News article
|
Smith, Chris
|
|
|
24 |
4 |
p. 635-636
|
artikel
|
| 20 |
Pancreatic islet autoantibodies and their association with glycemic status in cystic fibrosis patients: A comprehensive meta-analysis
|
Molnár, Regina
|
|
|
24 |
4 |
p. 733-740
|
artikel
|
| 21 |
Physical well-being and burden of care in adults on modulator therapy: A mixed methods study of patient-reported experiences from the Well-ME survey
|
Brown, Cynthia D.
|
|
|
24 |
4 |
p. 652-659
|
artikel
|
| 22 |
Primary care physician involvement increases likelihood of cancer screening in people with cystic fibrosis: A population-based study from Ontario, Canada
|
Stephenson, Anne L.
|
|
|
24 |
4 |
p. 698-703
|
artikel
|
| 23 |
Pulmonary endpoints in clinical trials for children with cystic fibrosis under two years of age
|
Lee, Tim
|
|
|
24 |
4 |
p. 669-683
|
artikel
|
| 24 |
Remote monitoring of cystic fibrosis lung disease in children and young adults
|
Svedberg, Marcus
|
|
|
24 |
4 |
p. 704-709
|
artikel
|
| 25 |
The role of islet CFTR in the development of cystic fibrosis-related diabetes: A semi-systematic review
|
Engström, Matilda
|
|
|
24 |
4 |
p. 724-732
|
artikel
|
| 26 |
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study
|
Nick, Jerry A․
|
|
|
24 |
4 |
p. 684-690
|
artikel
|
| 27 |
Vitality is associated with systemic inflammation in cystic fibrosis adults on elexacaftor/tezacaftor/ivacaftor
|
Gravelle, Jacob
|
|
|
24 |
4 |
p. 816-818
|
artikel
|
| 28 |
Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis
|
Van Citters, Aricca D.
|
|
|
24 |
4 |
p. 642-651
|
artikel
|
Tijdschrift beschrijving